Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?
Relkin
Norman
N
Cornell Memory Disorders Program, Weill Cornell Medical College, New York, NY, USA. nrelkin@mail.med.cornell.edu
D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D010166:Palliative Care
D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents